Suppr超能文献

护士在肠易激综合征管理中的作用：一项叙述性综述

The Role of the Nurse in the Management of Irritable Bowel Syndrome: A Narrative Review.

作者信息

Ruggiero Luigi, Andretta Vincenzo, Soldaini Carlo, Fricano Ivan, Mancusi Marco, Sellitti Annamaria, Vastarella Josephine, Santonicola Antonella

机构信息

Gastrointestinal Unit, Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Baronissi, SA, Italy.

AOU San Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy.

出版信息

Transl Med UniSa. 2023 Dec 22;25(1):28-37. doi: 10.37825/2239-9747.1043. eCollection 2023.

DOI:10.37825/2239-9747.1043
PMID:40303480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12038828/
Abstract

Irritable bowel syndrome (IBS) is characterized by chronic symptoms of abdominal pain in association with changes in bowel habits. Abdominal pain is the most debilitating symptom for IBS patients, and its management is one of the greatest challenges for gastroenterologists. In recent years more evidence has arisen about an increasingly central role of the nurse in the management of gastrointestinal diseases including IBS. The aim of this narrative review is to analyse the latest evidence on the pathophysiology, diagnosis, and treatment of IBS patients with a specific focus on the role of the nurse in its management.

摘要

肠易激综合征（IBS）的特征是伴有排便习惯改变的慢性腹痛症状。腹痛是IBS患者最使人衰弱的症状，对其进行管理是胃肠病学家面临的最大挑战之一。近年来，越来越多的证据表明护士在包括IBS在内的胃肠道疾病管理中发挥着越来越核心的作用。本叙述性综述的目的是分析IBS患者病理生理学、诊断和治疗的最新证据，特别关注护士在其管理中的作用。

相似文献

1
The Role of the Nurse in the Management of Irritable Bowel Syndrome: A Narrative Review.
Transl Med UniSa. 2023 Dec 22;25(1):28-37. doi: 10.37825/2239-9747.1043. eCollection 2023.
2
Physical activity for treatment of irritable bowel syndrome.
Cochrane Database Syst Rev. 2022 Jun 29;6(6):CD011497. doi: 10.1002/14651858.CD011497.pub2.
3
Food Intolerances, Food Allergies and IBS: Lights and Shadows.
Nutrients. 2024 Jan 16;16(2):265. doi: 10.3390/nu16020265.
4
A Narrative Review of Irritable Bowel Syndrome with Diarrhea: A Primer for Primary Care Providers.
Adv Ther. 2022 Sep;39(9):4003-4020. doi: 10.1007/s12325-022-02224-z. Epub 2022 Jul 22.
5
Chronic abdominal pain in irritable bowel syndrome - current and future therapies.
Expert Rev Clin Pharmacol. 2018 Jul;11(7):729-739. doi: 10.1080/17512433.2018.1494571. Epub 2018 Jul 9.
6
Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea.
Front Pharmacol. 2021 Feb 18;11:629026. doi: 10.3389/fphar.2020.629026. eCollection 2020.
7
Endocrine regulation of gut function - a role for glucagon-like peptide-1 in the pathophysiology of irritable bowel syndrome.
Exp Physiol. 2019 Jan;104(1):3-10. doi: 10.1113/EP087443. Epub 2018 Dec 10.
8
Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives.
Drug Des Devel Ther. 2020 Apr 9;14:1391-1400. doi: 10.2147/DDDT.S216056. eCollection 2020.
9
Managing pain in irritable bowel syndrome: current perspectives and best practice.
Expert Rev Gastroenterol Hepatol. 2023 Jul-Dec;17(9):871-881. doi: 10.1080/17474124.2023.2242775. Epub 2023 Aug 8.
10
Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
World J Gastroenterol. 2022 Sep 7;28(33):4861-4874. doi: 10.3748/wjg.v28.i33.4861.

本文引用的文献

1
Randomised, placebo-controlled trial and meta-analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The TRITON trial.
Aliment Pharmacol Ther. 2023 Jun;57(11):1258-1271. doi: 10.1111/apt.17426. Epub 2023 Mar 3.
2
Nurse practitioner-delivered cognitive-behavioral treatment as a novel implementation route for irritable bowel syndrome: A proof of concept.
Neurogastroenterol Motil. 2023 Apr;35(4):e14526. doi: 10.1111/nmo.14526. Epub 2023 Jan 20.
3
Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP).
Dig Liver Dis. 2023 Feb;55(2):187-207. doi: 10.1016/j.dld.2022.11.015. Epub 2022 Dec 11.
4
Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial.
Clin Nutr. 2022 Dec;41(12):2792-2800. doi: 10.1016/j.clnu.2022.11.001. Epub 2022 Nov 4.
5
How to Implement the 3-Phase FODMAP Diet Into Gastroenterological Practice.
J Neurogastroenterol Motil. 2022 Jul 30;28(3):343-356. doi: 10.5056/jnm22035.
6
The effect of self-management online modules plus nurse-led support on pain and quality of life among young adults with irritable bowel syndrome: A randomized controlled trial.
Int J Nurs Stud. 2022 Aug;132:104278. doi: 10.1016/j.ijnurstu.2022.104278. Epub 2022 Apr 30.
7
Association between irritable bowel syndrome and micronutrients: A systematic review.
J Gastroenterol Hepatol. 2022 Aug;37(8):1485-1497. doi: 10.1111/jgh.15891. Epub 2022 May 28.
8
Efficacy and Acceptability of Dietary Therapies in Non-Constipated Irritable Bowel Syndrome: A Randomized Trial of Traditional Dietary Advice, the Low FODMAP Diet, and the Gluten-Free Diet.
Clin Gastroenterol Hepatol. 2022 Dec;20(12):2876-2887.e15. doi: 10.1016/j.cgh.2022.02.045. Epub 2022 Feb 28.
9
A systematic review and meta-analysis on the prevalence of non-malignant, organic gastrointestinal disorders misdiagnosed as irritable bowel syndrome.
Sci Rep. 2022 Feb 4;12(1):1949. doi: 10.1038/s41598-022-05933-1.
10
Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population.
United European Gastroenterol J. 2021 Dec;9(10):1178-1188. doi: 10.1002/ueg2.12153. Epub 2021 Oct 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验